These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 27387859)
1. Understanding the Pathophysiology and Challenges of Development of Medical Countermeasures for Radiation-Induced Vascular/Endothelial Cell Injuries: Report of a NIAID Workshop, August 20, 2015. Satyamitra MM; DiCarlo AL; Taliaferro L Radiat Res; 2016 Aug; 186(2):99-111. PubMed ID: 27387859 [TBL] [Abstract][Full Text] [Related]
2. Medical countermeasures for platelet regeneration after radiation exposure. Report of a workshop and guided discussion sponsored by the National Institute of Allergy and Infectious Diseases, Bethesda, MD, March 22–23, 2010. DiCarlo AL; Poncz M; Cassatt DR; Shah JR; Czarniecki CW; Maidment BW Radiat Res; 2011 Jul; 176(1):e0001-15. PubMed ID: 21545291 [TBL] [Abstract][Full Text] [Related]
3. NIH Policies and Regulatory Pathways to U.S. FDA licensure: Strategies to Inform Advancement of Radiation Medical Countermeasures and Biodosimetry Devices. Satyamitra MM; Perez-Horta Z; DiCarlo AL; Cassatt DR; Rios CI; Price PW; Taliaferro LP Radiat Res; 2022 May; 197(5):533-553. PubMed ID: 35113982 [TBL] [Abstract][Full Text] [Related]
4. Product Development within the National Institutes of Health Radiation and Nuclear Countermeasures Program. Cassatt DR; DiCarlo AL; Molinar-Inglis O Radiat Res; 2024 May; 201(5):471-478. PubMed ID: 38407357 [TBL] [Abstract][Full Text] [Related]
5. Cellular Therapies for Treatment of Radiation Injury: Report from a NIH/NIAID and IRSN Workshop. DiCarlo AL; Tamarat R; Rios CI; Benderitter M; Czarniecki CW; Allio TC; Macchiarini F; Maidment BW; Jourdain JR Radiat Res; 2017 Aug; 188(2):e54-e75. PubMed ID: 28605260 [TBL] [Abstract][Full Text] [Related]
6. National Institutes of Health (NIH) Executive Meeting Summary: Developing Medical Countermeasures to Rescue Opioid-Induced Respiratory Depression (a Trans-Agency Scientific Meeting)-August 6/7, 2019. Yeung DT; Bough KJ; Harper JR; Platoff GE J Med Toxicol; 2020 Jan; 16(1):87-105. PubMed ID: 31853736 [TBL] [Abstract][Full Text] [Related]
7. Radiation-induced gastrointestinal and cutaneous injuries: understanding models, pathologies, assessments, and clinically accepted practices. Tamarat R; Satyamitra MM; Benderitter M; DiCarlo AL Int J Radiat Biol; 2024; 100(7):969-981. PubMed ID: 38787685 [TBL] [Abstract][Full Text] [Related]
8. Development of Biomarkers for Radiation Biodosimetry and Medical Countermeasures Research: Current Status, Utility, and Regulatory Pathways. Satyamitra MM; DiCarlo AL; Hollingsworth BA; Winters TA; Taliaferro LP Radiat Res; 2022 May; 197(5):514-532. PubMed ID: 34879151 [TBL] [Abstract][Full Text] [Related]
9. Animal Care in Radiation Medical Countermeasures Studies. Rios CI; Hollingsworth BA; DiCarlo AL; Esker JE; Satyamitra MM; Silverman TA; Winters TA; Taliaferro LP Radiat Res; 2022 Nov; 198(5):514-535. PubMed ID: 36001810 [TBL] [Abstract][Full Text] [Related]
10. Building the strategic national stockpile through the NIAID Radiation Nuclear Countermeasures Program. Rios CI; Cassatt DR; Dicarlo AL; Macchiarini F; Ramakrishnan N; Norman MK; Maidment BW Drug Dev Res; 2014 Feb; 75(1):23-8. PubMed ID: 24648046 [TBL] [Abstract][Full Text] [Related]
11. NIAID/NIH radiation/nuclear medical countermeasures product research and development program. Hafer N; Cassatt D; Dicarlo A; Ramakrishnan N; Kaminski J; Norman MK; Maidment B; Hatchett R Health Phys; 2010 Jun; 98(6):903-5. PubMed ID: 20445403 [TBL] [Abstract][Full Text] [Related]
12. A Trans-Agency Workshop on the Pathophysiology of Radiation-Induced Lung Injury. Cassatt DR; Gorovets A; Karimi-Shah B; Roberts R; Price PW; Satyamitra MM; Todd N; Wang SJ; Marzella L Radiat Res; 2022 Apr; 197(4):415-433. PubMed ID: 34342637 [TBL] [Abstract][Full Text] [Related]
13. A Trans-Agency Workshop on the Pathophysiology of Radiation-Induced Lung Injury. Satyamitra MM; Cassatt DR; Marzella L Radiat Res; 2022 Apr; 197(4):408-414. PubMed ID: 34714907 [TBL] [Abstract][Full Text] [Related]
14. The NIAID Radiation Countermeasures Program business model. Hafer N; Maidment BW; Hatchett RJ Biosecur Bioterror; 2010 Dec; 8(4):357-63. PubMed ID: 21142762 [TBL] [Abstract][Full Text] [Related]
15. Challenges and Benefits of Repurposing Products for Use during a Radiation Public Health Emergency: Lessons Learned from Biological Threats and other Disease Treatments. DiCarlo AL; Cassatt DR; Dowling WE; Esker JL; Hewitt JA; Selivanova O; Williams MS; Price PW Radiat Res; 2018 Dec; 190(6):659-676. PubMed ID: 30160600 [TBL] [Abstract][Full Text] [Related]
16. Interagency approaches to animal models for acute radiation exposure. Hunter KS; Carnell LS; DiCarlo AL; Hoffman CM; Loelius SG; Homer M Int J Radiat Biol; 2021; 97(sup1):S2-S5. PubMed ID: 34854794 [TBL] [Abstract][Full Text] [Related]
17. Animal models and medical countermeasures development for radiation-induced lung damage: report from an NIAID Workshop. Williams JP; Jackson IL; Shah JR; Czarniecki CW; Maidment BW; DiCarlo AL Radiat Res; 2012 May; 177(5):e0025-39. PubMed ID: 22468702 [TBL] [Abstract][Full Text] [Related]
20. Use of Growth Factors and Cytokines to Treat Injuries Resulting from a Radiation Public Health Emergency. Horta ZP; Case CM; DiCarlo AL Radiat Res; 2019 Jul; 192(1):92-97. PubMed ID: 31063041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]